Literature DB >> 3762875

High concentrations of cholecystokinin receptor binding sites in the ventromedial hypothalamic nucleus.

N C Day, M D Hall, C R Clark, J Hughes.   

Abstract

The detailed distribution of cholecystokinin (CCK) receptors in rat hypothalamic nuclei has been mapped using the technique of in vitro receptor autoradiography. Using 125I-CCK-8 as the radiolabelled probe, high levels of CCK receptor binding sites were observed in the ventromedial hypothalamic nucleus (VMN), with lower levels in the compact zone of the dorsomedial nucleus (CDMN). Computer-generated colour-coded image analysis of the VMN indicated that the level of 125I-CCK-8 binding in this nucleus approximated to that in the CCK-receptor rich cerebral cortex. Detailed distribution studies throughout the VMN indicated a marked differential localization of CCK receptor binding sites, with 125I-CCK-8 localized in a "halo" formation within the nucleus. The presence of CCK receptors within the VMN is supportive of an important role for CCK and its receptors in homeostatic processes mediated by the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762875     DOI: 10.1016/0143-4179(86)90059-4

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

1.  Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus.

Authors:  P Boden; R G Hill
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

2.  Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.

Authors:  T Griesbacher; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Molecular characterization of the mouse superior lateral parabrachial nucleus through expression of the transcription factor Runx1.

Authors:  Chrissandra J Zagami; Stefano Stifani
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.